Full and original article posted on Worcester Business Journal
Behind Central Massachusetts biotechnology research taking place to improve brain tumor procedures and genome editing techniques, or better treat addiction or pancreatic cancer, there’s one common element without which the work would be impossible.
Those initiatives and hundreds of others in Central Massachusetts have relied on funds from the National Institutes of Health, money contributing the bulk of work going to both major centers including UMass Medical School and Worcester Polytechnic Institute as well as small startups rising in their shadows.
“A lot of these ideas otherwise wouldn’t be able to necessarily advance,” said Jon Weaver, the president and CEO of Worcester biotech incubator Massachusetts Biomedical Initiatives (MBI), which works with several NIH funding recipients.
Click here to read full article.